Your point on NO COMPETITION in the LONG HAULERS arena.. is well taken..AND TRUE..In fact if done appropriately..may offer a back door entry for Leronlimab into the Covid Space..!!!
My concern as I stated ..is the PROTOCOL..!!! After decades of attending Investigator Meetings..Where the Protocol is discussed at nauseum with all the participating Physician Investigators..My opinion of the Pharma D who write these protocols..is VERY LOW.. In fact I think they’re PATHETIC..These include ALL major Pharmaceuticals..Merck..Pfizer..Sanofi..Etc..
Mistakes made in the Protocol..are often pointed out by Physicians..in the Investigator meetings..Ignored by the Pharmaceuticals..And paid dearly for in Protocol Amendments..that delay the completion of the trial by months.. in some cases ..years.. !!!
After seeing the farce of the Mild to Moderate Corona Trial..My opinion remains unchanged..!!!
My concern..as I stated in my previous post..is that Leronlimab not suffer the consequences of a poorly thought out or written Protocol..!!! Believe me..I’ve seen enough of those in my career..!!!
As always..It’s GREAT to be on this Board.. AND .. Do appreciate ALL the members giving their honest opinions..and sharing their expertise..!!!
Market Data 
Markets 
AI
